Joint Action on Market Surveillance of MD

The UK Medicines and Healthcare products Regulatory Agency and Chafea, executive agency of the European Commission have signed a Grant Agreement in order to reinforce market surveillance of medical devices between Competent Authorities and to harmonise the approach taken across all Member States.

The lead in the Joint Action 5 Work Packages was taken by the competent authorities of the UK (Coordination, Dissemination, Evaluation), the Netherlands (Joint Manufacturer Inspections) and Ireland (Clinical Process, Resource Development). Thus, we will particularly closely follow their work.

Here we present CAMD information leaflets for respective actors affected by this Joint Action:

Leave a Reply

Your email address will not be published.